Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Florence Thibaut & Hans-Jürgen Möller. (2012) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The World Journal of Biological Psychiatry 13:5, pages 318-378.
Read now
Read now
Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Hans-Jürgen Möller, WFSBP Task Force on Treatment Guidelines for Schizophrenia, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Hans-Jürgen Möller & WFSBP Task Force on Treatment Guidelines for Schizophrenia. (2005) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia. The World Journal of Biological Psychiatry 6:3, pages 132-191.
Read now
Read now
C Lyons, P McDonald, JE Maitland, JD Watson, DJ King & MF Mannion. (1998) Reduction in costs of inpatient stay associated with clozapine treatment: A retrospective study. Journal of Medical Economics 1:1-4, pages 69-79.
Read now
Read now
Jaspreet S. Brar, K. N. Roy Chengappa, Haranath Parepally, Alan R. Sandman, Suzanne B. Kreinbrook, Sapna A. Sheth & Rohan Ganguli. (1997) The Effects of Clozapine on Negative Symptoms in Patients with Schizophrenia with Minimal Positive Symptoms. Annals of Clinical Psychiatry 9:4, pages 227-234.
Read now
Read now